Efficacy and safety of EGFR-TKI combined with WBRT vs. WBRT alone in the treatment of brain metastases from NSCLC: a systematic review and meta-analysis

S Li, S Xu, L Li, Z Xue, L He - Frontiers in Neurology, 2024 - frontiersin.org
Background The efficacy and safety of combining epidermal growth factor receptor tyrosine
kinase inhibitors (EGFR-TKIs) with whole-brain radiotherapy (WBRT) for treating brain …
相关文章
[HTML] nih.gov

[HTML][HTML] Efficacy and safety of EGFR-TKI combined with WBRT vs. WBRT alone in the treatment of brain metastases from NSCLC: a systematic review and meta …

S Li, S Xu, L Li, Z Xue, L He - Frontiers in Neurology, 2024 - ncbi.nlm.nih.gov
Background The efficacy and safety of combining epidermal growth factor receptor tyrosine
kinase inhibitors (EGFR-TKIs) with whole-brain radiotherapy (WBRT) for treating brain …

Efficacy and safety of EGFR-TKI combined with WBRT vs. WBRT alone in the treatment of brain metastases from NSCLC: a systematic review and meta-analysis.

S Li, S Xu, L Li, Z Xue, L He - Frontiers in Neurology, 2024 - europepmc.org
Background The efficacy and safety of combining epidermal growth factor receptor tyrosine
kinase inhibitors (EGFR-TKIs) with whole-brain radiotherapy (WBRT) for treating brain …

Efficacy and safety of EGFR-TKI combined with WBRT vs. WBRT alone in the treatment of brain metastases from NSCLC: a systematic review and meta-analysis

S Li, S Xu, L Li, Z Xue, L He - Frontiers in neurology, 2024 - pubmed.ncbi.nlm.nih.gov
Background The efficacy and safety of combining epidermal growth factor receptor tyrosine
kinase inhibitors (EGFR-TKIs) with whole-brain radiotherapy (WBRT) for treating brain …